Clinical Trials Browser

Completed × Has results × ProMune × Clear all

NCT00199836 2022-10-10

A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer.

Phase 1 Completed

14 enrolled 11 charts

Neoplasms

NCT00490529 2020-01-13

Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL

Phase 2 Completed

59 enrolled 14 charts

Lymphoma, Mantle-Cell

NCT00880581 2017-03-14

A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas

Phase 2 Completed

30 enrolled 7 charts

Lymphoma, Lymphoma, Non-Hodgkin

NCT00438880 2016-02-04

Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma

Phase 1/2 Completed

38 enrolled 8 charts

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT00185965 2014-08-01

CPG 7909 + Local Radiotherapy in Recurrent Low-Grade Lymphomas

Phase 1/2 Completed

30 enrolled 6 charts

Lymphoma, Lymphoma, Non-Hodgkin, Mycoses, Mycosis Fungoides